share_log

Anebulo Pharmaceuticals Q2 EPS $(0.11) Misses $(0.10) Estimate

Anebulo Pharmaceuticals Q2 EPS $(0.11) Misses $(0.10) Estimate

Anebulo Pharmicals第二季度每股收益美元(0.11)未达到预期(0.10)
Moomoo 24/7 ·  02/13 16:43

Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.10) by 10 percent. This is a 26.67 percent increase over losses of $(0.15) per share from the same period last year.

Anebulo Pharmicals(纳斯达克股票代码:ANEB)公布的季度亏损为每股0.11美元,比分析师普遍预期的0.10美元(0.10美元)低10%。这比去年同期每股亏损0.15美元(0.15美元)增长了26.67%。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发